RE-BVS – Piemonte Repository

Sfoglia per AUTORE
CAMU W
Collezione AOU Città della Salute di Torino

Items : 6

Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic data. in Cell genomics / Cell Genom. 2024 Nov 13;4(11):100679. doi: 10.1016/j.xgen.2024.100679. Epub 2024 Oct 21.

2024
AOU Città della Salute di Torino
AOU Novara

Silani V; Siciliano G; Nath A; Wang T; Pasternack N; Doucet-O'Hare T; Johnson K; Gellera C; Ratti A; Pal S; Chandran S; D'Alfonso S; Cereda C; Sorarù G; Hardiman O; McLaughlin R; Al-Chalabi A; van den Berg LH; Scholz SW; Dalgard CL; Dobson RJB; Breen G; Shaw PJ; Cooper-Knock J; Morrison KE; Patel H; Chung R; Lee SH; Curtis CJ; et alii...

Author Correction: The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration. in Nature communications / Nat Commun. 2024 Jul 2;15(1):5560. doi: 10.1038/s41467-024-49938-y.

2024
AOU Città della Salute di Torino

Fogh I; Shatunov A; Mehta PR; Mayl K; Abel O; Topp SD; Iacoangeli A; Opie-Martin S; Bowles H; Limbachiya N; Spargo TP; Al-Khleifat A; Williams KL; Jockel-Balsarotti J; Bali T; Self W; Henden L; Nicholson GA; Ticozzi N; McKenna-Yasek D; Tang L; Shaw PJ; Chio A; Ludolph A; Weishaupt JH; Landers JE; Glass JD; Mora JS; Robberecht W; et alii...

The HFE p.H63D (p.His63Asp) Polymorphism Is a Modifier of ALS Outcome in Italian and French Patients with SOD1 Mutations. in Biomedicines / Biomedicines. 2023 Feb 24;11(3):704. doi: 10.3390/biomedicines11030704.

2023
AOU Città della Salute di Torino

Canosa A; Calvo A; Mora G; Moglia C; Brunetti M; Barberis M; Borghero G; Caponnetto C; Trojsi F; Spataro R; Volanti P; Simone IL; Salvi F; Logullo FO; Riva N; Tremolizzo L; Giannini F; Mandrioli J; Tanel R; Murru MR; Mandich P; Conforti FL; Zollino M; Sabatelli M; Tarlarini C; Lunetta C; Mazzini L; D'Alfonso S; Guy N; et alii...

The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration. in Nature communications / Nat Commun. 2022 Nov 12;13(1):6901. doi: 10.1038/s41467-022-34620-y.

2022
AOU Città della Salute di Torino

Opie-Martin S; Iacoangeli A; Topp SD; Abel O; Mayl K; Mehta PR; Shatunov A; Fogh I; Bowles H; Limbachiya N; Spargo TP; Al-Khleifat A; Williams KL; Jockel-Balsarotti J; Bali T; Self W; Henden L; Nicholson GA; Ticozzi N; McKenna-Yasek D; Tang L; Shaw PJ; Chio A; Ludolph A; Weishaupt JH; Landers JE; Glass JD; Mora JS; Robberecht W; et alii...

Clinical trials in pediatric ALS: a TRICALS feasibility study. in Amyotrophic lateral sclerosis & frontotemporal degeneration / Amyotroph Lateral Scler Frontotemporal Degener. 2022 Nov;23(7-8):481-488. doi: 10.1080/21678421.2021

2022
AOU Città della Salute di Torino

Stevic Z; SorarÙ G; Sarafov S; Salachas F; Rubio MÁ; Roes KCB; Riva N; Reviers E; Povedano M; Petri S; Mora JS; Mcdermott CJ; Meyer T; Mandrioli J; Lunetta C; Leigh PN; Lambert T; Kuzma-Kozakiewicz M; Koritnik B; Ingre C; HØyer H; HolmØy T; Hanemann CO; Grosskreutz J; GarcÍa Redondo A; Filosto M; Esteban J; Van Es MA; Desnuelle C; et alii...

Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis. in JAMA neurology / JAMA Neurol. 2021 Oct 1;78(10):1236-1248. doi: 10.1001/jamaneurol.2021.2598.

2021
AOU Città della Salute di Torino
AOU Novara

Tremolizzo L; Trojsi F; Torriello A; Tranquilli S; Tedeschi G; Ticca A; Tanel R; Simonini C; Spataro R; Simone I; Sbaiz L; Sideri R; Santarelli M; Salivetto M; Salvi F; Sabatelli M; Salamone P; Riolo G; Riva N; Russo M; Ricci C; Pugliatti M; Quattrini A; Pozzi S; Petrelli C; Petrucci A; Passaniti C; Origone P; Murru MR; et alii...